Clinical Trials Logo

Clinical Trial Summary

The goal of this non-interventional study is to investigate the safety, efficacy and tolerability of Ectoin Lozenges Honey Lemon (EHT02) compared to lozenges containing hyaluronic acid and islandic moss in the treatment of acute viral pharyngitis.


Clinical Trial Description

The current non-interventional study aims to investigate the efficacy and tolerability of Ectoin Lozenges Honey Lemon in patients suffering from acute viral pharyngitis. Participants receive treatments as part of routine medical care, and participants can choose one of two treatment options: a) Ectoin Lozenges Honey Lemon or b) lozenges containing hyaluronic acid and icelandic moss.

Efficacy will be studied by documentation of the following symptoms:

- pain on swallowing

- hoarseness

- urge to cough

- dry mouth and throat

- redness of oropharynx and larynx

- sore throat

- impairment of free breathing

- general feeling of illness

In parallel, participating patients will document their symptoms over the entire study duration in patient diaries.

The observation takes place over a period of seven days. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03943186
Study type Observational
Source Bitop AG
Contact
Status Completed
Phase
Start date December 13, 2018
Completion date May 13, 2019

See also
  Status Clinical Trial Phase
Completed NCT02669446 - Ectoin® Lozenges in the Treatment of Acute Viral Pharyngitis N/A